Should Pharma come clean?

S
#MSBlog: Should pharma companies release clinical data to the public?

Nigel Hawkes. Drug companies should release data from all trials of licensed drugs, say MPs. BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f321

The drug industry should be obliged to release in a publicly accessible form all the information it possesses about trials of licensed drugs, the House of Commons Health Committee has said in a new report on the functioning of the National Institute for Health and Clinical Excellence (NICE). It should be “neither legal nor ethical” to withhold such data, said the committee. It was concerned that failure to observe this simple principle undermined the effectiveness of NICE, because the institute was forced to appraise drugs without having access to all relevant data.



“This demand is nothing new. Ben Goldacre has been saying this for awhile in various publications and talks. GSK has recently launched an initiative do make its data accessible. You may be interested to know that I am in the process of becoming the custodian of the cladribine data. So there things afoot and I suspect it will only be a matter of time before all trial data is available to the public.”

Other posts of interest

19 Jul 2012
Ben Goldacre has been able to criticize Big Pharma without resorting to science denialism and I believe that Prof G and his team have been nothing but forthright with their experiences with Big Pharma. Posted by Maria to 
23 Mar 2012
If any one is interested in social phenomena that disconnect with the predominant scientific opinion of the time should also read “Bad Science” by Ben Goldacre; the book provides the social context to the CCSVI phenomenon 
05 Oct 2012
How effective treatment for MS may be stalled by the greed of big Pharma and the short-sightedness of NICE. ReplyDelete · MouseDoctor Saturday, October 06, 2012 11:54:00 pm. Maybe Ben Goldacre can do the programme.
06 Nov 2012
Innocent victims are dying at the hands of big pharma just so that some MSers in Europe and America can access an overpriced product that probably won’t do much for them in the long run. Even Ben Goldacre has been on 
18 Jul 2012
Ben Goldacre has been able to criticize Big Pharma without resorting to science denialism and I believe that Prof G and his team have been nothing but forthright with their experiences with Big Pharma. ReplyDelete 

About the author

Prof G

Professor of Neurology, Barts & The London. MS & Preventive Neurology thinker, blogger, runner, vegetable gardener, husband, father, cook and wine & food lover.

3 comments

  • This is interesting information, and this Ben Goldacre character seems to be onto something he may be a bit overboard but I like they way he thinks. The study Data should be available to consumers, I am sure there is nothing to hide

By Prof G

Translate

Categories

Recent Posts

Recent Comments

Archives